an affiliate of
     
We Need Your help as a 50 State Network Advocate!
Now is your time to be heard
Join Seth’s 50 State Network here
Seth’s 50 State Network is a grassroots advocacy organization comprised of patients like you. We are working to share the patient perspective, which is crucial in the State and Federal health policy and regulatory arenas. Patients need a voice in all conversations that relate to our access to treatment, safety, or the quality of our care. This community is made up of patients living with diverse chronic illnesses, including rheumatoid arthritis, lupus, and psoriasis, and the people who care about them. Seth’s 50 State Network is about transforming pain into purpose, empowering those that may feel victimized by disease. Our focus is on repurposing the energy of frustration, despair, and helplessness into positive mobilization, action, and fair representation to benefit all of us. Our formula, which we offer to our fellow patients and their loved ones, is to take lemons and make lemonade.
Letters and Testimony
IMG_0311
Texas Pharmaceutical & Therapeutics Committee – July Meeting outcome

On July 24th, the Texas Pharmaceutical and Therapeutics (P&T) Committee, a part of the Texas Health and Human Services Commission, convened to review a number of different medications and medication classes for entry onto their Preferred Drug List (PDL) of the Texas Medicaid Formulary. A medication to alleviate symptoms of opioid-induced constipation (OIC) was one […]

Events
jaffee_headshot 2013
7/9/2015 – Teleconference with Assemblywoman Jaffee

Assemblywoman Jaffee provided our listeners with some important advice about the power of the patient perspective. Listen to what she had to say:

GHLF in the news
Modern Medicine Logo
5 reasons biosimilars must have distinguishable names

If you ask patients with severe chronic diseases, such as those with rheumatoid arthritis, cancer, or multiple sclerosis, what they believe is the most important factor in achieving a positive outcome for their condition or disease, the vast majority will say it’s the relationship they have with their physician and treatment team.